These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Effect of preoperative long-term use of corticosteroids on the development of post-transplant lymphoproliferative disorders after lung transplantation: a single-center experience in Japan. Shimizu D; Otani S; Sugimoto S; Yamamoto H; Tomioka Y; Shiotani T; Miyoshi K; Okazaki M; Yamane M; Toyooka S Surg Today; 2022 Apr; 52(4):697-704. PubMed ID: 34694493 [TBL] [Abstract][Full Text] [Related]
28. Posttransplant lymphoproliferative disorders in lung transplant recipients: clinical experience at a single center. Angel LF; Cai TH; Sako EY; Levine SM Ann Transplant; 2000; 5(3):26-30. PubMed ID: 11147026 [TBL] [Abstract][Full Text] [Related]
29. Systematic review and meta-analysis of post-transplant lymphoproliferative disorder in lung transplant recipients. Cheng J; Moore CA; Iasella CJ; Glanville AR; Morrell MR; Smith RB; McDyer JF; Ensor CR Clin Transplant; 2018 May; 32(5):e13235. PubMed ID: 29517815 [TBL] [Abstract][Full Text] [Related]
30. Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients. Reams BD; McAdams HP; Howell DN; Steele MP; Davis RD; Palmer SM Chest; 2003 Oct; 124(4):1242-9. PubMed ID: 14555552 [TBL] [Abstract][Full Text] [Related]
31. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy. Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG; Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361 [TBL] [Abstract][Full Text] [Related]
32. Posttransplant lymphoproliferative disease after lung transplantation. Neuringer IP Clin Dev Immunol; 2013; 2013():430209. PubMed ID: 23533455 [TBL] [Abstract][Full Text] [Related]
33. Lymphoproliferative Disorders after Lung Transplantation: Clinicopathological Characterization of 16 Cases with Identification of Very-Late-Onset Forms. Thomas de Montpréville V; Le Pavec J; Le Roy Ladurie F; Crutu A; Mussot S; Fabre D; Mercier O; Dorfmuller P; Ghigna MR; Fadel É Respiration; 2015; 90(6):451-459. PubMed ID: 26506523 [TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic characteristics of post-transplant lymphoproliferative disorders. Nalesnik MA Recent Results Cancer Res; 2002; 159():9-18. PubMed ID: 11785849 [TBL] [Abstract][Full Text] [Related]
35. Otolaryngological manifestations of posttransplant lymphoproliferative disorder in pediatric thoracic transplant patients. Herrmann BW; Sweet SC; Hayashi RJ; Canter CE; White FV; Lieu JE Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):303-10. PubMed ID: 16125255 [TBL] [Abstract][Full Text] [Related]
36. Discrimination of Epstein-Barr virus-related posttransplant lymphoproliferations from acute rejection in lung allograft recipients. Rosendale B; Yousem SA Arch Pathol Lab Med; 1995 May; 119(5):418-23. PubMed ID: 7748068 [TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus serology and posttransplant lymphoproliferative disease in lung transplantation. Wigle DA; Chaparro C; Humar A; Hutcheon MA; Chan CK; Keshavjee S Transplantation; 2001 Dec; 72(11):1783-6. PubMed ID: 11740388 [TBL] [Abstract][Full Text] [Related]